Outer Membrane Protein B1 as a Vaccine for Branhamella Catarrhalis
The present invention encompasses nucleotide sequences derived from Moraxella catarrhalis which encode one or more epitopes of its outer membrane protein B1. Recombinant B1 protein or B1 peptides may be produced from genetically engineered host cells that contain and express these nucleotide sequences. The nucleotide sequences can be used in diagnostic assays for detecting M. catarrhalis genetic material. These sequences may also be used in antigenic compositions to produce B1-specific amino a cids for the purpose of eliciting an immune response.
Categories: Therapeutic and Vaccines
Patents Issues: 5,972,657
Patents:US 5,972,657
Type of Offer:
Licensing
« More Pharmaceutical Patents